» Articles » PMID: 35064432

The Alberta Moving Beyond Breast Cancer (AMBER) Cohort Study: Baseline Description of the Full Cohort

Abstract

Purpose: The Alberta Moving Beyond Breast Cancer (AMBER) Study is an ongoing prospective cohort study investigating how direct measures of physical activity (PA), sedentary behavior (SB), and health-related fitness (HRF) are associated with survival after breast cancer.

Methods: Women in Alberta with newly diagnosed stage I (≥ T1c) to IIIc breast cancer were recruited between 2012 and 2019. Baseline assessments were completed within 90 days of surgery. Measurements included accelerometers to measure PA and SB; a graded treadmill test with gas exchange analysis to measure cardiorespiratory fitness (VO); upper and lower body muscular strength and endurance; dual-X-ray absorptiometry to measure body composition; and questionnaires to measure self-reported PA and SB.

Results: At baseline, the 1528 participants' mean age was 56 ± 11 years, 59% were post-menopausal, 62% had overweight/obesity, and 55% were diagnosed with stage II or III disease. Based on device measurements, study participants spent 8.9 ± 1.7 h/day sedentary, 4.4 ± 1.2 h/day in light-intensity activity, 0.9 ± 0.5 h/day in moderate-intensity activity, and 0.2 ± 0.2 h/day in vigorous-intensity activity. For those participants who reached VO, the average aerobic fitness level was 26.6 ± 6 ml/kg/min. Average body fat was 43 ± 7.1%.

Conclusion: We have established a unique cohort of breast cancer survivors with a wealth of data on PA, SB, and HRF obtained through both direct and self-reported measurements. Study participants are being followed for at least ten years to assess all outcomes after breast cancer. These data will inform clinical and public health guidelines on PA, SB, and HRF for improving breast cancer outcomes.

Citing Articles

Baseline Characteristics of Participants in the Alberta Cancer Exercise Hybrid Effectiveness-Implementation Study: A Wake-Up Call for Action.

McNeely M, Shallwani S, Williamson T, Sellar C, Gobeil E, Joy A Cancers (Basel). 2025; 17(5).

PMID: 40075620 PMC: 11898868. DOI: 10.3390/cancers17050772.


The Breast to Bone (B2B) Cohort Study to Prevent, Detect and Improve Treatment of Metastatic Disease: Baseline Assessment, Description and Progress.

Brockton N, Cook L, Magliocco A, Shemanko C, Vogel H, Khan M Int J Environ Res Public Health. 2025; 22(2).

PMID: 40003468 PMC: 11855345. DOI: 10.3390/ijerph22020242.


The Physical Activity and Cancer Control (PACC) framework: update on the evidence, guidelines, and future research priorities.

Yang L, Courneya K, Friedenreich C Br J Cancer. 2024; 131(6):957-969.

PMID: 38926526 PMC: 11405831. DOI: 10.1038/s41416-024-02748-x.


Associations between health-related fitness and patient-reported symptoms in newly diagnosed breast cancer patients.

An K, Arthuso F, Filion M, Allen S, Ntoukas S, Bell G J Sport Health Sci. 2024; 13(6):851-862.

PMID: 38697290 PMC: 11336311. DOI: 10.1016/j.jshs.2024.04.012.


Upper Limb Morbidity in Newly Diagnosed Individuals After Unilateral Surgery for Breast Cancer: Baseline Results from the AMBER Cohort Study.

McNeely M, Courneya K, Al Onazi M, Wharton S, Wang Q, Dickau L Ann Surg Oncol. 2023; 30(13):8389-8397.

PMID: 37755568 DOI: 10.1245/s10434-023-14316-3.


References
1.
Brenner D, Weir H, Demers A, Ellison L, Louzado C, Shaw A . Projected estimates of cancer in Canada in 2020. CMAJ. 2020; 192(9):E199-E205. PMC: 7055947. DOI: 10.1503/cmaj.191292. View

2.
Ganz P, Hahn E . Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008; 26(5):759-67. DOI: 10.1200/JCO.2007.14.2851. View

3.
Bodai B, Tuso P . Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J. 2015; 19(2):48-79. PMC: 4403581. DOI: 10.7812/TPP/14-241. View

4.
Brennan M, Houssami N . Overview of long term care of breast cancer survivors. Maturitas. 2011; 69(2):106-12. DOI: 10.1016/j.maturitas.2011.03.010. View

5.
Odle T . Adverse effects of breast cancer treatment. Radiol Technol. 2014; 85(3):297M-319M. View